業績

{ 304件 }

Nakamura H, Fujieda Y, Tarumi M, Kitakawa H, Hisada R, Nakagawa I, Noguchi A, Kurita T, Kataoka H, Kasahara H, Amasaki Y, Yokota I,
Atsumi T
Calcineurin Inhibitors for Adult-Onset Still’s Disease: A Multi-Center Epidemiological Study
Clin Exp Rheumatol
IF: 3.238

  • 2020
  • 膠原病グループ
  • 欧文論文/原著

Wen Shi Lee and Olga Amengual.
Cells targeting therapy in the management of systemic lupus erythematosus.
Immunological Medicine.
Accepted 25 November,2019 in press

  • 2020
  • 膠原病グループ
  • 欧文論文/総説
  • 2019
  • 膠原病グループ
  • 2019
  • 腎臓グループ

Watanabe-Kusunoki K, Nakazawa D, Kusunoki Y, Kudo T, Hattanda F, Nishio S, Masuda S, Tomaru U, Kondo T, Atsumi T, Ishizu A.

Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection.
Journal of Autoimmunity. 2019. PMID: 31883830

  • 2019
  • 腎臓グループ
  • 欧文論文/原著

Maeda T, Kitamura S, Yanagi T,  Narahira A, Miyamoto K, Hata H, Cho KY, Kameda H, Nakamura A, Shimizu H.

Type 1 diabetes mellitus in a melanoma patient treated with adjuvant nivolumab therapy.

Journal of Cutaneous Immunology and Allergy. 2019.

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Metin-Armagan D, Comunoglu N, Bulut G, Kadioglu P, Kameda H, Gazioglu N, Tanriover N, Ozturk M.
A Novel Expression Profile of Cell Cycle and DNA Repair Proteins in Nonfunctioning Pituitary Adenomas
Endocrine Pathology. 2019. PMID: 31828584

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nomoto H, Montemurro C, Pei L, Rosenberger M, Furterer A, Coppola G, Nadel B, Pellegrini M, Gurlo T, Butler PC, Tudzarova S.

Activation of the HIF1α/PFKFB3 stress response pathway in beta-cells in type 1 diabetes.

Diabetologia. 2019. PMID: 31720731

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nomoto H, Gurlo T, Girgis M, Dry SM, Rosenberger M, Butler PC. 

Low Grade Islet but Marked Exocrine Pancreas Inflammation in an Adult with Autoimmune Pre-Diabetes.

Case Reports in Endocrinology. 2019. 

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Cho KY, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, Nagai S, Tsuchida K, Omori K, Yokoyama H, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.

Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).

Diabetes, Obesity and Metabolism. 2019. PMID: 31486230

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著